Adoptive Cell Transfer Therapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 113 pages | ID: AFBE86C2062BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Adoptive Cell Transfer Therapy in Global, including the following market information:

Global Adoptive Cell Transfer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Adoptive Cell Transfer Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

NK Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Adoptive Cell Transfer Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adoptive Cell Transfer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Adoptive Cell Transfer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Type, 2021 (%)

• NK
• LAK
• DC
• CIK
• CTL
• TIL
• TCR-T
• CAR-T

Global Adoptive Cell Transfer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Application, 2021 (%)

• Acute Lymphocytic Leukemia
• NHL
• Melanoma
• Bladder Cancer
• Lung Cancer
• Head and Neck Cancer
• Multiple Myeloma
• Other

Global Adoptive Cell Transfer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Adoptive Cell Transfer Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Adoptive Cell Transfer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Adoptive Cell Transfer Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Kite Pharma
• Pfizer
• Juno Therapeutics
• Celgene Corporation
• CARsgen Therapeutics
• Sorrento Therapeutics
• Legend Biotech
• Atara Biotherapeutics
• Aurora Biopharma
• Autolus Therapeutics PLC
• Bluebird
• Carina Biotech
• Athenex
• Xiangxue Pharmaceutical (Xiangxue Precision)
• Hengrui Yuanzheng
• Eureka Therapeutics
• WuXi Juno
• Shenzhen Inno Immunity
• Shenzhen Binde Bio
• Kerui Bio
• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Takara Bio
• Unum Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Adoptive Cell Transfer Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Adoptive Cell Transfer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADOPTIVE CELL TRANSFER THERAPY OVERALL MARKET SIZE

2.1 Global Adoptive Cell Transfer Therapy Market Size: 2021 VS 2028
2.2 Global Adoptive Cell Transfer Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Adoptive Cell Transfer Therapy Players in Global Market
3.2 Top Global Adoptive Cell Transfer Therapy Companies Ranked by Revenue
3.3 Global Adoptive Cell Transfer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adoptive Cell Transfer Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Adoptive Cell Transfer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Adoptive Cell Transfer Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Adoptive Cell Transfer Therapy Market Size Markets, 2021 & 2028
  4.1.2 NK
  4.1.3 LAK
  4.1.4 DC
  4.1.5 CIK
  4.1.6 CTL
  4.1.7 TIL
  4.1.8 TCR-T
  4.1.9 CAR-T
4.2 By Type - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
  4.2.1 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Adoptive Cell Transfer Therapy Market Size, 2021 & 2028
  5.1.2 Acute Lymphocytic Leukemia
  5.1.3 NHL
  5.1.4 Melanoma
  5.1.5 Bladder Cancer
  5.1.6 Lung Cancer
  5.1.7 Head and Neck Cancer
  5.1.8 Multiple Myeloma
  5.1.9 Other
5.2 By Application - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
  5.2.1 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Adoptive Cell Transfer Therapy Market Size, 2021 & 2028
6.2 By Region - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
  6.2.1 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Adoptive Cell Transfer Therapy Revenue, 2017-2028
  6.3.2 US Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.3.3 Canada Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.3.4 Mexico Adoptive Cell Transfer Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Adoptive Cell Transfer Therapy Revenue, 2017-2028
  6.4.2 Germany Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.3 France Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.4 U.K. Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.5 Italy Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.6 Russia Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.4.8 Benelux Adoptive Cell Transfer Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Adoptive Cell Transfer Therapy Revenue, 2017-2028
  6.5.2 China Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.5.3 Japan Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.5.4 South Korea Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.5.6 India Adoptive Cell Transfer Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Adoptive Cell Transfer Therapy Revenue, 2017-2028
  6.6.2 Brazil Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.6.3 Argentina Adoptive Cell Transfer Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, 2017-2028
  6.7.2 Turkey Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.7.3 Israel Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Adoptive Cell Transfer Therapy Market Size, 2017-2028
  6.7.5 UAE Adoptive Cell Transfer Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Adoptive Cell Transfer Therapy Major Product Offerings
  7.1.4 Novartis AG Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 Kite Pharma
  7.2.1 Kite Pharma Corporate Summary
  7.2.2 Kite Pharma Business Overview
  7.2.3 Kite Pharma Adoptive Cell Transfer Therapy Major Product Offerings
  7.2.4 Kite Pharma Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.2.5 Kite Pharma Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Adoptive Cell Transfer Therapy Major Product Offerings
  7.3.4 Pfizer Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Juno Therapeutics
  7.4.1 Juno Therapeutics Corporate Summary
  7.4.2 Juno Therapeutics Business Overview
  7.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.4.4 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.4.5 Juno Therapeutics Key News
7.5 Celgene Corporation
  7.5.1 Celgene Corporation Corporate Summary
  7.5.2 Celgene Corporation Business Overview
  7.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Major Product Offerings
  7.5.4 Celgene Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.5.5 Celgene Corporation Key News
7.6 CARsgen Therapeutics
  7.6.1 CARsgen Therapeutics Corporate Summary
  7.6.2 CARsgen Therapeutics Business Overview
  7.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.6.4 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.6.5 CARsgen Therapeutics Key News
7.7 Sorrento Therapeutics
  7.7.1 Sorrento Therapeutics Corporate Summary
  7.7.2 Sorrento Therapeutics Business Overview
  7.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.7.4 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.7.5 Sorrento Therapeutics Key News
7.8 Legend Biotech
  7.8.1 Legend Biotech Corporate Summary
  7.8.2 Legend Biotech Business Overview
  7.8.3 Legend Biotech Adoptive Cell Transfer Therapy Major Product Offerings
  7.8.4 Legend Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.8.5 Legend Biotech Key News
7.9 Atara Biotherapeutics
  7.9.1 Atara Biotherapeutics Corporate Summary
  7.9.2 Atara Biotherapeutics Business Overview
  7.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.9.4 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.9.5 Atara Biotherapeutics Key News
7.10 Aurora Biopharma
  7.10.1 Aurora Biopharma Corporate Summary
  7.10.2 Aurora Biopharma Business Overview
  7.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Major Product Offerings
  7.10.4 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.10.5 Aurora Biopharma Key News
7.11 Autolus Therapeutics PLC
  7.11.1 Autolus Therapeutics PLC Corporate Summary
  7.11.2 Autolus Therapeutics PLC Business Overview
  7.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Major Product Offerings
  7.11.4 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.11.5 Autolus Therapeutics PLC Key News
7.12 Bluebird
  7.12.1 Bluebird Corporate Summary
  7.12.2 Bluebird Business Overview
  7.12.3 Bluebird Adoptive Cell Transfer Therapy Major Product Offerings
  7.12.4 Bluebird Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.12.5 Bluebird Key News
7.13 Carina Biotech
  7.13.1 Carina Biotech Corporate Summary
  7.13.2 Carina Biotech Business Overview
  7.13.3 Carina Biotech Adoptive Cell Transfer Therapy Major Product Offerings
  7.13.4 Carina Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.13.5 Carina Biotech Key News
7.14 Athenex
  7.14.1 Athenex Corporate Summary
  7.14.2 Athenex Business Overview
  7.14.3 Athenex Adoptive Cell Transfer Therapy Major Product Offerings
  7.14.4 Athenex Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.14.5 Athenex Key News
7.15 Xiangxue Pharmaceutical (Xiangxue Precision)
  7.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Corporate Summary
  7.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
  7.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Major Product Offerings
  7.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Key News
7.16 Hengrui Yuanzheng
  7.16.1 Hengrui Yuanzheng Corporate Summary
  7.16.2 Hengrui Yuanzheng Business Overview
  7.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Major Product Offerings
  7.16.4 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.16.5 Hengrui Yuanzheng Key News
7.17 Eureka Therapeutics
  7.17.1 Eureka Therapeutics Corporate Summary
  7.17.2 Eureka Therapeutics Business Overview
  7.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.17.4 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.17.5 Eureka Therapeutics Key News
7.18 WuXi Juno
  7.18.1 WuXi Juno Corporate Summary
  7.18.2 WuXi Juno Business Overview
  7.18.3 WuXi Juno Adoptive Cell Transfer Therapy Major Product Offerings
  7.18.4 WuXi Juno Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.18.5 WuXi Juno Key News
7.19 Shenzhen Inno Immunity
  7.19.1 Shenzhen Inno Immunity Corporate Summary
  7.19.2 Shenzhen Inno Immunity Business Overview
  7.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Major Product Offerings
  7.19.4 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.19.5 Shenzhen Inno Immunity Key News
7.20 Shenzhen Binde Bio
  7.20.1 Shenzhen Binde Bio Corporate Summary
  7.20.2 Shenzhen Binde Bio Business Overview
  7.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Major Product Offerings
  7.20.4 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.20.5 Shenzhen Binde Bio Key News
7.21 Kerui Bio
  7.21.1 Kerui Bio Corporate Summary
  7.21.2 Kerui Bio Business Overview
  7.21.3 Kerui Bio Adoptive Cell Transfer Therapy Major Product Offerings
  7.21.4 Kerui Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.21.5 Kerui Bio Key News
7.22 Adaptimmune
  7.22.1 Adaptimmune Corporate Summary
  7.22.2 Adaptimmune Business Overview
  7.22.3 Adaptimmune Adoptive Cell Transfer Therapy Major Product Offerings
  7.22.4 Adaptimmune Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.22.5 Adaptimmune Key News
7.23 Altor Bioscience Corporation
  7.23.1 Altor Bioscience Corporation Corporate Summary
  7.23.2 Altor Bioscience Corporation Business Overview
  7.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Major Product Offerings
  7.23.4 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.23.5 Altor Bioscience Corporation Key News
7.24 Cellectis
  7.24.1 Cellectis Corporate Summary
  7.24.2 Cellectis Business Overview
  7.24.3 Cellectis Adoptive Cell Transfer Therapy Major Product Offerings
  7.24.4 Cellectis Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.24.5 Cellectis Key News
7.25 Takara Bio
  7.25.1 Takara Bio Corporate Summary
  7.25.2 Takara Bio Business Overview
  7.25.3 Takara Bio Adoptive Cell Transfer Therapy Major Product Offerings
  7.25.4 Takara Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.25.5 Takara Bio Key News
7.26 Unum Therapeutics
  7.26.1 Unum Therapeutics Corporate Summary
  7.26.2 Unum Therapeutics Business Overview
  7.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
  7.26.4 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.26.5 Unum Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Adoptive Cell Transfer Therapy Market Opportunities & Trends in Global Market
Table 2. Adoptive Cell Transfer Therapy Market Drivers in Global Market
Table 3. Adoptive Cell Transfer Therapy Market Restraints in Global Market
Table 4. Key Players of Adoptive Cell Transfer Therapy in Global Market
Table 5. Top Adoptive Cell Transfer Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Adoptive Cell Transfer Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Adoptive Cell Transfer Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Adoptive Cell Transfer Therapy Product Type
Table 9. List of Global Tier 1 Adoptive Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Adoptive Cell Transfer Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Adoptive Cell Transfer Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Adoptive Cell Transfer Therapy Product Offerings
Table 32. Novartis AG Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Kite Pharma Corporate Summary
Table 34. Kite Pharma Adoptive Cell Transfer Therapy Product Offerings
Table 35. Kite Pharma Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Adoptive Cell Transfer Therapy Product Offerings
Table 38. Pfizer Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Juno Therapeutics Corporate Summary
Table 40. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 41. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporation Corporate Summary
Table 43. Celgene Corporation Adoptive Cell Transfer Therapy Product Offerings
Table 44. Celgene Corporation Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CARsgen Therapeutics Corporate Summary
Table 46. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 47. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Sorrento Therapeutics Corporate Summary
Table 49. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 50. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Legend Biotech Corporate Summary
Table 52. Legend Biotech Adoptive Cell Transfer Therapy Product Offerings
Table 53. Legend Biotech Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Atara Biotherapeutics Corporate Summary
Table 55. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 56. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Aurora Biopharma Corporate Summary
Table 58. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offerings
Table 59. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Autolus Therapeutics PLC Corporate Summary
Table 61. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offerings
Table 62. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Bluebird Corporate Summary
Table 64. Bluebird Adoptive Cell Transfer Therapy Product Offerings
Table 65. Bluebird Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Carina Biotech Corporate Summary
Table 67. Carina Biotech Adoptive Cell Transfer Therapy Product Offerings
Table 68. Carina Biotech Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 69. Athenex Corporate Summary
Table 70. Athenex Adoptive Cell Transfer Therapy Product Offerings
Table 71. Athenex Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 72. Xiangxue Pharmaceutical (Xiangxue Precision) Corporate Summary
Table 73. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offerings
Table 74. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 75. Hengrui Yuanzheng Corporate Summary
Table 76. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offerings
Table 77. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 78. Eureka Therapeutics Corporate Summary
Table 79. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 80. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 81. WuXi Juno Corporate Summary
Table 82. WuXi Juno Adoptive Cell Transfer Therapy Product Offerings
Table 83. WuXi Juno Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 84. Shenzhen Inno Immunity Corporate Summary
Table 85. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offerings
Table 86. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 87. Shenzhen Binde Bio Corporate Summary
Table 88. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offerings
Table 89. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 90. Kerui Bio Corporate Summary
Table 91. Kerui Bio Adoptive Cell Transfer Therapy Product Offerings
Table 92. Kerui Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 93. Adaptimmune Corporate Summary
Table 94. Adaptimmune Adoptive Cell Transfer Therapy Product Offerings
Table 95. Adaptimmune Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 96. Altor Bioscience Corporation Corporate Summary
Table 97. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offerings
Table 98. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 99. Cellectis Corporate Summary
Table 100. Cellectis Adoptive Cell Transfer Therapy Product Offerings
Table 101. Cellectis Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 102. Takara Bio Corporate Summary
Table 103. Takara Bio Adoptive Cell Transfer Therapy Product Offerings
Table 104. Takara Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 105. Unum Therapeutics Corporate Summary
Table 106. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 107. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Adoptive Cell Transfer Therapy Segment by Type in 2021
Figure 2. Adoptive Cell Transfer Therapy Segment by Application in 2021
Figure 3. Global Adoptive Cell Transfer Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adoptive Cell Transfer Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adoptive Cell Transfer Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2021
Figure 8. By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 12. US Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 24. China Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kite Pharma Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Corporation Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Legend Biotech Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bluebird Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Carina Biotech Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Athenex Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. WuXi Juno Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Kerui Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Adaptimmune Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Cellectis Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Takara Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)